Long-Term Study Shows Givinostat’s Promise for Duchenne Muscular Dystrophy Treatment

ITF Therapeutics has announced the publication of encouraging long-term data supporting the efficacy and safety of givinostat as a treatment for Duchenne muscular dystrophy (DMD), according to a recent article…

Continue Reading Long-Term Study Shows Givinostat’s Promise for Duchenne Muscular Dystrophy Treatment